Qian Shi
Papers
1
Total Citations
42
H-Index
1
About
Dr. Qian Shi has made pioneering contributions to the field of cancer biomarker discovery, with a particular focus on breast cancer diagnostics. Her landmark 2006 study, "Declining Plasma Fibrinogen Alpha Fragment Identifies HER2-Positive Breast Cancer Patients and Reverts to Normal Levels after Surgery," which has garnered 42 citations, represents a significant breakthrough in non-invasive cancer detection. This work addressed a critical gap in oncology: the absence of simple, blood-based diagnostic tests to complement radiological screening for HER2-positive breast cancer, the most common nonskin malignancy affecting women. By employing automated proteomic techniques to screen plasma specimens, Dr. Shi identified the fibrinogen alpha fragment as a dynamic biomarker that not only detects HER2-positive breast cancer but also normalizes following surgical intervention. This discovery holds profound implications for early detection, treatment monitoring, and reducing reliance on invasive biopsies. Dr. Shi's research exemplifies the translational power of proteomics in oncology, offering hope for more accessible and sensitive cancer diagnostics. Her work continues to inspire further investigation into blood-based biomarkers, positioning her as a key figure in the quest to improve breast cancer outcomes through molecular profiling.
Research Focus
Key Achievements
Top Papers
- 1